PD L1 News and Research

RSS
Different anti-PD-L1 antibodies show varied results in tumor growth inhibition

Different anti-PD-L1 antibodies show varied results in tumor growth inhibition

New diagnostic test identifies head and neck cancer patients curable by surgery alone

New diagnostic test identifies head and neck cancer patients curable by surgery alone

Radiation primes the immune system to attack lung tumors resistant to immunotherapy

Radiation primes the immune system to attack lung tumors resistant to immunotherapy

Cuproptosis offers new hope for treating inflammatory bowel disease and colorectal cancer

Cuproptosis offers new hope for treating inflammatory bowel disease and colorectal cancer

New mRNA vaccine strategy awakens immune system to fight cancer

New mRNA vaccine strategy awakens immune system to fight cancer

Research unravels the immune secrets of a cured pediatric rhabdoid tumor

Research unravels the immune secrets of a cured pediatric rhabdoid tumor

Engineered exosomal spheres enhance melanoma immunotherapy through improved tumor penetration

Engineered exosomal spheres enhance melanoma immunotherapy through improved tumor penetration

Metabolic enzyme PHGDH found to play a surprising role in breast cancer immunity

Metabolic enzyme PHGDH found to play a surprising role in breast cancer immunity

Gut microbe emerges as a promising tool in the fight against COVID-19

Gut microbe emerges as a promising tool in the fight against COVID-19

Targeting IGF2BP1 offers a new approach to cancer therapy

Targeting IGF2BP1 offers a new approach to cancer therapy

FDA approval of pembrolizumab marks major shift in head and neck cancer treatment

FDA approval of pembrolizumab marks major shift in head and neck cancer treatment

Navigating the dual role of B cells in tumor immunity

Navigating the dual role of B cells in tumor immunity

Myeloid cells shape tumor microenvironments and influence cancer progression

Myeloid cells shape tumor microenvironments and influence cancer progression

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Combination treatment extends progression-free survival in advanced skin cancer

Combination treatment extends progression-free survival in advanced skin cancer

TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer

TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer

Immunotherapy before and after surgery boost longer event-free survival in head and neck cancer

Immunotherapy before and after surgery boost longer event-free survival in head and neck cancer

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

Immune evasion found in early stages of HPV-related anogenital lesions

Immune evasion found in early stages of HPV-related anogenital lesions

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.